A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

PHASE3RecruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Thyroid Eye Disease (TED)
Interventions
DRUG

VRDN-003

VRDN-003 is an investigational, subcutaneously administered, humanized monoclonal antibody directed against the Insulin-like Growth Factor-1 receptor (IGF-1R).

DRUG

Placebo

Placebo injections that appear identical to VRDN-003 injections but have no active drug.

Trial Locations (47)

14012

RECRUITING

Hospital La Arruzafa, Córdoba

15706

RECRUITING

Hospital Provincial de Conxo, A Coruña

28034

RECRUITING

Hospital Universitario Ramon y Cajal, Madrid

32216

RECRUITING

East Coast Institute for Research, LLC, Jacksonville

33024

RECRUITING

Alfa Medical Research, Davie

33034

RECRUITING

Sina Medical Center, Homestead

33125

RECRUITING

Southern Clinical Research LLC, Miami

33132

RECRUITING

D H Doral Research Center, Doral

33134

RECRUITING

Herco Medical and Research Center, Coral Gables

33135

RECRUITING

Retreat Medical Research, Miami

33144

RECRUITING

Continental Clinical Research, Miami

33317

RECRUITING

Edward Jenner Research Group LLC, Plantation

33901

RECRUITING

Eye Centers of Florida, Fort Myers

33990

RECRUITING

C A Clinical Trial Corp., Cape Coral

34239

RECRUITING

Sarasota Retina Institute, Sarasota

37075

RECRUITING

Universitaetsmedizin Goettingen, Göttingen

38305

RECRUITING

Jackson Clinic, Jackson

41009

RECRUITING

Hospital Universitario Virgen Macarena, Seville

48026

RECRUITING

Fraser Eye Care Center, Fraser

60462

RECRUITING

Advanced Quality Medical Research, Orland Park

64108

RECRUITING

University of Missouri Kansas City, Kansas City

75010

RECRUITING

DFW Clinical Trials, Carrollton

77074

RECRUITING

Neuro Eye Clinical Trials, Houston

77099

RECRUITING

Pioneer Research Solutions Inc., Houston

77586

RECRUITING

Elevate Clinical Research, Seabrook

78240

RECRUITING

San Antonio Clinical Trials, San Antonio

78258

RECRUITING

Eyeplastx, San Antonio

85712

RECRUITING

Catalina Eye Care, Tuscon

90301

RECRUITING

United Medical Research Institute, Inglewood

90404

RECRUITING

Pacific Neuroscience Institute, Santa Monica

90503

RECRUITING

Pacific Neuroscience Institute at Saint John's Physician Partners, Torrance

91107

RECRUITING

California Eye Specialists Medical Group INC, Pasadena

92660

RECRUITING

Orbital Plastics, Newport Beach

02189

RECRUITING

Ophthalmic Consultants of Boston, East Weymouth

07103

RECRUITING

Rutgers New Jersey Medical School, Newark

15-276

RECRUITING

Uniwersytecki Szpital Kliniczny w Białymstoku, Klinika Okulistyki, Centrum Badań Klinicznych, Bialystok

80-180

RECRUITING

Optimum Profesorskie Centrum Okulistyki Sp. z o. o., Gdansk

81-338

RECRUITING

Centrum Medyczne Pratia Gdynia, Gdynia

90-302

RECRUITING

Santa Familia PTG Lodz, Lodz

20-412

RECRUITING

ETG Lublin, Lublin

05-500

RECRUITING

Centrum Medyczne Pulawska Sp. z o.o., Piaseczno

01-258

RECRUITING

Warszawski Szpital Okulistyczny, Warsaw

02-777

RECRUITING

Polimedica PTG, Warsaw

08017

RECRUITING

Institut Català de Retina, Barcelona

07059

RECRUITING

Akdeniz Üniversitesi Tıp Fakültesi Göz Hastalıkları Anabilim Dalı, Antalya

NW1 5QH

RECRUITING

Imperial College Healthcare NHS Trust, London

SE1 7EH

RECRUITING

Guy's and St Thomas' NHS Foundation Trust, London

All Listed Sponsors
lead

Viridian Therapeutics, Inc.

INDUSTRY